NIH R01 · 2024
Personalized lesion modification optimizes atherosclerosis intervention
The past half-century has seen an amazing trend. Linked advances in vascular biology, endovascular intervention and drug delivery have dropped morality from cardiovascular disease 4.5 fold. NIH support has blessed us with involvement in these endeavors and we are humbled by the accomplishments of the community. Yet, atherosclerotic disease is not eradicated, we do not fully grasp the vascular biology of obstructive vascular diseases, and interventional therapy is not at a standardized consensus. There is much to be learned in all areas especially for complex lesions where lesion modification is deemed indispensable. Increasingly sophisticated methods (e.g. orbital atherectomy, lithotripsy…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.